Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era

BJU International

Volumn 113, Issue 4, 2014, Pages 598-604

  Kim, Kwang Hyun ^a,c   Lim, Sey Kiat ^a   Kim, Ha Yan ^b   Han, Woong Kyu ^a   Choi, Young Deuk ^a   Chung, Byung Ha ^a   Hong, Sung Joon ^a   Rha, Koon Ho ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Mokdong Hospital   (South Korea)

Author keywords

lymph node excision; nomograms; prostatectomy; prostatic neoplasm

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; ASIAN; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CHEMOLUMINESCENCE; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NOMOGRAM; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; ROBOTICS; SENSITIVITY AND SPECIFICITY; YONSEI NOMOGRAM;

LYMPH NODE EXCISION; NOMOGRAMS; PROSTATECTOMY; PROSTATIC NEOPLASM;

AGED; ASIA; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NOMOGRAMS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROBOTICS;

EID: 84896404978     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12280     Document Type: Article

References (38)

1. von Bodman C, Godoy G, Chade DC, et al. Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. J Urol 2010; 184: 143-148
2. Boorjian SA, Thompson RH, Siddiqui S, et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol 2007; 178: 864-870
3. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491-2499
4. Schiavina R, Scattoni V, Castellucci P, et al. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol 2008; 54: 392-401
5. Messing EM, Manola J, Yao J, et al. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 2006; 7: 472-479
6. Wong Y, Freedland S, Egleston B, Hudes G, Schwartz JS, Armstrong K,. Role of androgen deprivation therapy for node-positive prostate cancer. J Clin Oncol 2009; 27: 100-105
7. Loblaw DA, Virgo KS, Nam R, et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2007; 25: 1596-1605
8. Feifer AH, Elkin EB, Lowrance WT, et al. Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy. Cancer 2011; 117: 3933-3942
9. NCCN Clinical Practice Guidelines in Oncology. 2013. Prostate Cancer. Available at: http://www.nccn.org/professionals/physician-gls/pdf/prostate.pdf. Accessed July 2013
10. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011; 59: 61-71
11. Briganti A, Larcher A, Abdollah F, et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 2012; 61: 480-487
12. Godoy G, Chong KT, Cronin A, et al. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement. Eur Urol 2011; 60: 195-201
13. Song C, Ro JY, Lee M, et al. Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology 2006; 68: 820-824
14. Byun S, Lee S, Lee E, et al. Recent changes in the clinicopathologic features of Korean men with prostate cancer: a comparison with Western populations. Yonsei Med J 2012; 53: 543-549
15. Song C, Kang T, Ro JY, Lee M, Kim C, Ahn H,. Nomograms for the prediction of pathologic stage of clinically localized prostate cancer in Korean men. J Korean Med Sci 2005; 20: 262-266
16. Chung JS, Choi HY, Song H, et al. Nomogram to predict insignificant prostate cancer at radical prostatectomy in Korean men: a multi-center study. Yonsei Med J 2011; 52: 74-80
17. Naito S, Kuroiwa K, Kinukawa N, et al. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer. J Urol 2008; 180: 904-909
18. Martinez-Salamanca JI, Huang WC, Millan I, et al. Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol 2011; 59: 120-127
19. Cagiannos I, Karakiewicz P, Eastham JA, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003; 170: 1798-1803
20. Briganti A, Chun FK, Salonia A, et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 2006; 49: 1019-1026
21. Briganti A, Karakiewicz PI, Chun FK, et al. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Eur Urol 2007; 51: 1573-1581
22. Hansen J, Rink M, Bianchi M, et al. External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection. Prostate 2013; 73: 211-218
23. SchrÃder F, Kattan MW,. The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review. Eur Urol 2008; 54: 274-290
24. Shariat SF, Karakiewicz PI, Suardi N, Kattan MW,. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res 2008; 14: 4400-4407
25. Taksler GB, Keating NL, Cutler DM,. Explaining racial differences in prostate cancer mortality. Cancer 2012; 118: 4280-4289
26. Shao Y, Demissie K, Shih W, et al. Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 2009; 101: 1280-1283
27. Li X, Zhang D, Cui X, et al. Evaluating the oncologic outcomes in 152 patients undergoing extraperitoneal laparoscopic radical prostatectomy. Chin Med J 2012; 125: 1529-1535
28. Egawa S, Suyama K, Arai Y, et al. Treatment outcome by risk group after radical prostatectomy in Japanese men. Int J Urol 2001; 8: 295-300
29. Man A, Pickles T, Chi KN,. Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer. J Urol 2003; 170: 901-904
30. Chung JS, Choi HY, Song H, et al. Preoperative nomograms for predicting extracapsular extension in Korean men with localized prostate cancer: a multi-institutional clinicopathologic study. J Korean Med Sci 2010; 25: 1443-1448
31. Jeong CW, Jeong SJ, Hong SK, et al. Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis. Int J Urol 2012; 19: 846-852
32. DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML,. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 2005; 173: 1121-1125
33. Berglund RK, Sadetsky N, DuChane J, Carroll PR, Klein EA,. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE. J Urol 2007; 177: 526-529
34. Joslyn SA, Konety BR,. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 2006; 68: 121-125
35. Masterson TA, Bianco FJ, Vickers AJ, et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 2006; 175: 1320-1324
36. Ji J, Yuan H, Wang L, Hou J,. Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study. J Surg Res 2012; 178: 779-784
37. Feicke A, Baumgartner M, Talimi S, et al. Robotic-assisted laparoscopic extended pelvic lymph node dissection for prostate cancer: surgical technique and experience with the first 99 cases. Eur Urol 2009; 55: 876-883
38. Yuh BE, Ruel NH, Mejia R, Wilson CM, Wilson TG,. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer. Eur Urol 2012; 61: 1004-1010